ERK1/2-mediated vasoconstriction normalizes wall stress in small mesenteric arteries during NOS inhibition in vivo

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 3, 2003, Pages 339-347

  Girardot, Daphné ^a   Demeilliers, Bénédicte ^a   DeBlois, Denis ^a   Moreau, Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

ERK1 2; NO; Small artery contraction; Vascular remodeling; Wall stress

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; MALE; MESENTERIC ARTERY; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; MALE; MESENTERIC ARTERIES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, CARDIOVASCULAR; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; RENIN; VASOCONSTRICTION;

EID: 0041837594     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200309000-00004     Document Type: Article

References (44)

1. Rees D, Palmer R, Moncada S. Role of endothelium-derived nitric oxide relaxing factor in the regulation of blood pressure. Proc Natl Acad Sci USA. 1989;86:3375-3378.
2. Riberio M, Antunes E, De Nucci G, et al. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension. 1992;20:298-303.
3. Taddei S, Virdis A, Mattei P, et al. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.
4. Falloon B, Heagerty A. In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension. 1994;24:16-23.
5. Dominiczak A, Bohr D. Nitric oxide and its putative role in hypertension. Hypertension. 1995;25:1202-1211.
6. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral tone in man. Lancet. 1989;2:997-1000.
7. Sakai H, Hara H, Tsai A, et al. Constriction of resistance arteries determines L-NAME-induced hypertension in a conscious hamster model. Microvasc Res. 1999;60:21-27.
8. Kato H, Hou J, Chobanian AV, et al. Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta. Hypertension. 1996;28:153-158.
9. Laurent S. Arterial wall hypertrophy and stiffness in essential hypertension patients. Hypertension. 1995;26:355-362.
10. Deng L, Thibault G, Schiffrin E. Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat. Clin Exp Hypertens. 1993;15:527-537.
11. Moreau P, Takase H, Kung C, et al. Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition. Stroke. 1995;26:1922-1929.
12. Mulvany MJ, Baumbach GL, Aalkjaer C, et al. Vascular remodeling (letter). Hypertension. 1996;28:505-506.
13. Mulvany M. Small artery remodeling in hypertension. Curr Hypertens Rep. 2002;4:49-55.
14. Boudier H. Arteriolar and capillary remodeling in hypertension. Drugs. 1999;58:43-47.
15. le Noble F, Stassen F, Hacking W, et al. Angiogenesis and hypertension. J Hypertens. 1998;16:1563-1572.
16. Vicaut E. Microcirculation and arterial hypertension. Drugs. 1999;58:1-11.
17. Xu Q, Liu Y, Goroscope M, et al. Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest. 1996;97:508-514.
18. Allen S, Liang H, Hill M, et al. Elevated pressure stimulates protooncogene expression in isolated mesenteric arteries. Am J Physiol. 1996;271: H1517-H1523.
19. Wesselman J, Dobrian A, Schriver S, et al. Src tyrosine kinases and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases mediate pressure-induced C-Fos expression in cannulated rat mesenteric small arteries. Hypertension. 2001;37:955-960.
20. Allen S, Wade S, Prewitt R. Myogenic tone attenuates pressure-induced gene expression in isolated small arteries. Hypertension. 1997;30:203-208.
21. Bakker EN, van Der Meulen ET, Spaan JA, et al. Organoid culture of cannulated rat resistance arteries: effect of serum factors on vasoactivity and remodeling. Am J Physiol. 2000;278:H1233-H1240.
22. Bakker EN, van der Meulen ET, van den Berg BM, et al. Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res. 2002;39:12-20.
23. Martens FM, Demeilliers B, Girardot D, et al. Vessel-specific stimulation of protein synthesis by nitric oxide synthase inhibition: role of extracellular signal-regulated kinases 1/2. Hypertension. 2002;39:6-21.
24. Thouyz R, Mabrouk E, He G, et al. Mitogen-activated protein/ extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in SHR vascular smooth muscle cells. Circ Res. 1999;84:505-515.
25. Thouyz R, He G, Deng L, et al. Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscles cells from human resistance arteries. Circulation. 1999;99:392-399.
26. Matrougui K, Eskildsen-Helmond Y, Fiebeler A, et al. Angiotensin III stimulates extracellular signal-regulated kinase activity in intact pressurized rat Mesenteric Resistance Arteries. Hypertension. 2000;36:617-621.
27. Moreau P. Effect of chronic nitric oxide deficiency on angiotensin II-induced hypertrophy of rat basilar artery. Stroke. 1998;29:1031-1036.
28. Takase H, Moreau P, Kung C, et al. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Hypertension. 1996;27:25-31.
29. Heagerty A, Izzard A. Small-artery changes in hypertension. J Hypertens. 1995;13:1560-1565.
30. Servant MJ, Giasson E, Meloche S. Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. J Biol Chem. 1996;271:16047-16052.
31. Boudreau N, Jones P. Extracellular matrix and integrin signalling: the shape of things to come. Biochem Soc. 1999;339:481-488.
32. Giancotti F, Ruoslahti E. Integrin Signaling. Science. 1999;285:1028-1032.
33. Goldschmidt M, McLeod K, Taylor W. Integrin-mediated mechanotransduction in vascular smooth muscle cells: frequency and force response characteristics. Circ Res. 2001;88:674-480.
34. Alessi D, Cuanda A, Cohen P, et al. PD 098059 is a specific inhibitor of the activation of MAPK in vitro and in vivo. J Biol Chem. 1995;270:27489-27494.
35. Greenblatt E, Loeb A, Longnecher D. Marked regional heterogeneity in the magnitude of EDRF/NO-mediated vascular tone in awake rats. J Cardiovasc Pharmacol. 1992;21:235-240.
36. Moreau P, Takase H, Kung C, et al. Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension. Hypertension. 1997;29:763-769.
37. Takemoto M, Egashira K, Tomita H, et al. Chronic angiotensin-converting enzyme inhibition and angiotensin II type I receptor blockade: effects on cardiovascular remodeling in rats induced by long-term blockade of nitric oxide synthesis. Hypertension. 1997;30:1621-1627.
38. Zanchi A, Schaad N, Osterheld M-C, et al. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system. Am J Physiol. 1995:H2267-H2273.
39. Suzuki E, Nagata D, Kakoki M, et al. Molecular mechanisms of endothelin-1-induced cell-cycle progression: involvement of extracellular signal-regulated kinase, protein kinase C, and phosphatidylinositol 3-kinase at distinct points. Circ Res. 1999;84:611-619.
40. Thouyz R, Deng L, He G, et al. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. J Hypertens. 1999;17:907-916.
41. Yu S, Tsai S, Guh J, et al. Mechanisms of catecholamine-induced proliferation of vascular smooth muscle cells. Circulation. 1996;94:547-554.
42. Dao HH, Martens FM, Lariviere R, et al. Transient involvement of endothelin in hypertrophic remodeling of small arteries. J Hypertens. 2001;19:1801-1812.
43. Banting J, Friberg P, Adams M. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J Hypertens. 1996;14:975-981.
44. Richard V, Hogie M, Clozel M, et al. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation. 1995;91:771-775.